RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--PharPoint Research, a contract research organization (CRO) headquartered in North Carolina, is once again a recipient of the Triangle Business Journal’s Fast 50 award, which highlights 50 of the fastest growing companies in the Triangle area. This is the fourth time the company has received this honor.
Each honoree is selected and ranked based on a formula that counts revenue growth and profitability in the preceding three years (2013 – 2015). The data are processed and analyzed by PricewaterhouseCoopers and the rankings will be revealed during the Fast 50 Awards dinner on November 9.
PharPoint has increased their presence in the pharmaceutical industry over the past 12 months, by now providing clinical development services for global trials. “Our global expertise offers Sponsors access to emerging markets and heightens our management of clinical trials,” says PharPoint CEO, Art Holmes.
The company has evolved into a full-service CRO over the past decade and developed processes to manage trial logistics in a completely virtual environment to improve transparency and information exchange with Sponsors. “Our clients are a testament to our success,” continues Holmes. “Our growth is a direct result of the strong relationships we build with Sponsors and partners alike. Companies turn to PharPoint for our team’s breadth of therapeutic and program expertise, horizontal business structure, and study execution capabilities. We are proud to be recognized by the Triangle Business Journal for our continued level of service to our clients.”
PharPoint Research is a full-service contract research organization (CRO) that specializes in data management, biostatistics, clinical monitoring, and medical writing. The company is uniquely poised to serve the needs of pharmaceutical, biotechnology, and medical device development organizations. PharPoint Research is experienced in strategic consulting engagements and Phase 1 through Phase 4 clinical research projects across a variety of therapeutic areas, including cardiovascular, central nervous system (CNS), infectious disease, oncology, and rare disease indications. PharPoint Research is headquartered in Research Triangle Park, N.C., with strategic technology partners and service providers around the world, including North and South America, Europe, and Asia-Pacific. For more information, please visit pharpoint.com.